
Eric Olson
Examiner (ID: 3855, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1693, 1673 |
| Total Applications | 1706 |
| Issued Applications | 961 |
| Pending Applications | 123 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8363685
[patent_doc_number] => 08252750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale'
[patent_app_type] => utility
[patent_app_number] => 10/460170
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 11595
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460170 | Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale | Jun 12, 2003 | Issued |
Array
(
[id] => 8363685
[patent_doc_number] => 08252750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale'
[patent_app_type] => utility
[patent_app_number] => 10/460170
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 11595
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460170 | Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale | Jun 12, 2003 | Issued |
Array
(
[id] => 8363685
[patent_doc_number] => 08252750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale'
[patent_app_type] => utility
[patent_app_number] => 10/460170
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 11595
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460170 | Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale | Jun 12, 2003 | Issued |
Array
(
[id] => 7097322
[patent_doc_number] => 20050129780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Relief of aids symptoms'
[patent_app_type] => utility
[patent_app_number] => 10/515773
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6477
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515773 | Relief of aids symptoms | May 28, 2003 | Abandoned |
Array
(
[id] => 5851789
[patent_doc_number] => 20060234980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food'
[patent_app_type] => utility
[patent_app_number] => 10/516234
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5230
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234980.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516234 | Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food | May 28, 2003 | Abandoned |
Array
(
[id] => 4583776
[patent_doc_number] => 07851450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Gangliosides with a modified acyl function'
[patent_app_type] => utility
[patent_app_number] => 10/497173
[patent_app_country] => US
[patent_app_date] => 2003-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4531
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/851/07851450.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497173
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497173 | Gangliosides with a modified acyl function | May 26, 2003 | Issued |
Array
(
[id] => 5716101
[patent_doc_number] => 20060079464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Peritoneal dialysate containing taurine'
[patent_app_type] => utility
[patent_app_number] => 10/520243
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3051
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079464.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520243 | Peritoneal dialysate containing taurine | May 22, 2003 | Abandoned |
Array
(
[id] => 13722
[patent_doc_number] => 07807656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Pharmaceutical applications of hyaluronic acid preparations'
[patent_app_type] => utility
[patent_app_number] => 10/495200
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3778
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495200 | Pharmaceutical applications of hyaluronic acid preparations | May 21, 2003 | Issued |
Array
(
[id] => 7289613
[patent_doc_number] => 20040110296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Conjugates and compositions for cellular delivery'
[patent_app_type] => new
[patent_app_number] => 10/427160
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 52356
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110296.pdf
[firstpage_image] =>[orig_patent_app_number] => 10427160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/427160 | Conjugates and compositions for cellular delivery | Apr 29, 2003 | Issued |
Array
(
[id] => 6945269
[patent_doc_number] => 20050197318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Fucose containing proteoglycan or acidic glycan and their pharmaceutical use'
[patent_app_type] => utility
[patent_app_number] => 10/423855
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8147
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20050197318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10423855
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/423855 | Fucose containing proteoglycan or acidic glycan and their pharmaceutical use | Apr 24, 2003 | Issued |
Array
(
[id] => 142469
[patent_doc_number] => 07691986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'High molecular weight, low methoxyl pectins, and their production and uses'
[patent_app_type] => utility
[patent_app_number] => 10/422867
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16733
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691986.pdf
[firstpage_image] =>[orig_patent_app_number] => 10422867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/422867 | High molecular weight, low methoxyl pectins, and their production and uses | Apr 22, 2003 | Issued |
Array
(
[id] => 7200202
[patent_doc_number] => 20050164980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Hyaluronic acid modification product'
[patent_app_type] => utility
[patent_app_number] => 10/511707
[patent_app_country] => US
[patent_app_date] => 2003-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10396
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0164/20050164980.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511707 | Hyaluronic acid modification product | Apr 17, 2003 | Issued |
Array
(
[id] => 6770408
[patent_doc_number] => 20030216348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Aminosugar, glycosaminoglycan, and S-Adenosylmethionine composition for the treatment and repair of connective tissue'
[patent_app_type] => new
[patent_app_number] => 10/408255
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7562
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216348.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408255
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408255 | Aminosugar, glycosaminoglycan, and S-Adenosylmethionine composition for the treatment and repair of connective tissue | Apr 7, 2003 | Abandoned |
Array
(
[id] => 880540
[patent_doc_number] => 07355039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Building additives based on purified hydrophobically modified hydroxyalkyl guar'
[patent_app_type] => utility
[patent_app_number] => 10/508274
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2357
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/355/07355039.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508274 | Building additives based on purified hydrophobically modified hydroxyalkyl guar | Mar 11, 2003 | Issued |
Array
(
[id] => 833634
[patent_doc_number] => 07396924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Building additives based on purified hydroxyalkyl guar'
[patent_app_type] => utility
[patent_app_number] => 10/508320
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2427
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396924.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508320
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508320 | Building additives based on purified hydroxyalkyl guar | Mar 11, 2003 | Issued |
Array
(
[id] => 7270586
[patent_doc_number] => 20040059104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Nucleotide mimics and their prodrugs'
[patent_app_type] => new
[patent_app_number] => 10/376654
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35527
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20040059104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10376654
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/376654 | Nucleotide mimics and their prodrugs | Feb 27, 2003 | Issued |
Array
(
[id] => 6840416
[patent_doc_number] => 20030145763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Flocculant or binder composition, slurry containing the flocculant or binder composition, method for making ceramics using the slurry, and ceramic products made therefrom'
[patent_app_type] => new
[patent_app_number] => 10/371135
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8285
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20030145763.pdf
[firstpage_image] =>[orig_patent_app_number] => 10371135
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/371135 | Flocculant or binder composition, slurry containing the flocculant or binder composition, method for making ceramics using the slurry, and ceramic products made therefrom | Feb 20, 2003 | Abandoned |
Array
(
[id] => 7097864
[patent_doc_number] => 20050130323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Inhibitor for adhesion of metal hydroxide-containing substance to waste liquor line of automatic analyzer'
[patent_app_type] => utility
[patent_app_number] => 10/504581
[patent_app_country] => US
[patent_app_date] => 2003-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6280
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504581
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504581 | Inhibitor for adhesion of metal hydroxide-containing substance to waste liquor line of automatic analyzer | Feb 16, 2003 | Abandoned |
Array
(
[id] => 7061695
[patent_doc_number] => 20050004057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Chitosan oligosaccharides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/498001
[patent_app_country] => US
[patent_app_date] => 2002-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3965
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498001
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498001 | Chitosan oligosaccharides and uses thereof | Dec 15, 2002 | Abandoned |
Array
(
[id] => 7133680
[patent_doc_number] => 20040043066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Levothyroxine compositions having unique triiodothyronine Tmax properties'
[patent_app_type] => new
[patent_app_number] => 10/282972
[patent_app_country] => US
[patent_app_date] => 2002-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16224
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043066.pdf
[firstpage_image] =>[orig_patent_app_number] => 10282972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/282972 | Levothyroxine compositions having unique triiodothyronine Tmax properties | Oct 28, 2002 | Abandoned |